MIR4747: A Drug Target / Disease Biomarker (G100616337)
MIR4747: A Drug Target / Disease Biomarker
MIR4747, also known as interleukin-4747, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-4 family, which includes other proteins such as IL-1, IL-2, and IL-3. These proteins are involved in the regulation of immune and inflammatory responses.
One of the things that makes MIR4747 an interesting drug target is its role in the regulation of skin health. The skin is one of the most delicate and sensitive organs in the body, and it is constantly being exposed to external environmental factors such as the sun, pollution, and stress. As a result, the skin needs to be able to respond quickly and effectively to these stimuli in order to maintain its health.
MIR4747 plays a key role in this response by regulating the production of a group of proteins called cytokines. These proteins are involved in the recruitment of immune cells to the site of an injury or infection, as well as the regulation of inflammation. By controlling the production of these proteins, MIR4747 is able to fine-tune the immune response and help to protect the skin from damage.
Another important function of MIR4747 is its role in the regulation of cell signaling. Many different types of cells in the body communicate with one another through the production and reception of chemical messengers called signaling proteins. These signaling proteins can either activate or inhibit the activity of other proteins, and they play a crucial role in the regulation of many different physiological processes.
MIR4747 is involved in this process by producing a type of signaling protein called a cytokine. These cytokines are able to communicate with other cells through the use of special structures called cytoskeins. These structures are made up of a protein called GFP, which is a light-colored protein that is able to be easily visualized in the body using a special type of microscope.
By producing these cytokines, MIR4747 is able to communicate with other cells and coordinate their activities. This is important for the regulation of many different physiological processes, including immune responses, cell signaling, and tissue repair.
In addition to its role in immune and inflammatory responses, MIR4747 is also involved in the regulation of cell death. Many different types of cells in the body have a specific time limit for how long they can survive before they are replaced with new cells. This is important for the maintenance of tissue homeostasis and for the regulation of many different physiological processes.
MIR4747 is involved in this process by producing a protein called Bcl-2. This protein is involved in the regulation of cell death, and it is able to prevent cells from undergoing an unnecessary process of cell division. This is important for the regulation of many different diseases, including cancer, and it is also important for the maintenance of tissue homeostasis.
Another potential drug target for MIR4747 is its role in the regulation of the blood supply. The blood supply is a critical resource for many different physiological processes, and it is important for the delivery of oxygen and nutrients to the body's cells. MIR4747 is involved in this process by regulating the production of a protein called Integrin alpha-2, which is involved in the stickiness of blood vessels.
By regulating the production of Integrin alpha-2, MIR4747 is able to control the stickiness of blood vessels and improve the delivery of oxygen and nutrients to the body's cells. This is important for the regulation of many different physiological processes, including blood pressure, blood flow, and oxygenation of tissues.
In conclusion, MIR4747 is a protein that plays a
Protein Name: MicroRNA 4747
The "MIR4747 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4747 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507
